SPHERE LIFE and IMMUNEXIS present the REGENERATOR SF-01 at SEC 2026

SPHERE LIFE and IMMUNEXIS took part in the international SEC 2026 exhibition, where they presented the innovative physiotherapeutic device REGENERATOR SF-01. The event brought together representatives of the medical, biotechnology, and wellness industries from around the world and served as a platform for showcasing advanced solutions in healthcare and restorative medicine.

The REGENERATOR SF-01 attracted significant interest from visitors due to its scientifically grounded approach to physiotherapy. The device operates using controlled physical therapeutic factors with intensification of ion-exchange processes, aimed at supporting regenerative processes in the body and activating non-specific protective mechanisms.

During the exhibition, the SPHERE LIFE and IMMUNEXIS teams presented experimental research findings related to the device’s effects on cellular processes, including its potential role in antiviral response modulation and interferonogenesis. These materials generated interest among physicians, researchers, and representatives of medical centers seeking non-pharmacological and supportive therapeutic approaches.

In addition to the device demonstration, company representatives actively engaged with the professional audience to discuss potential applications of the REGENERATOR SF-01 in physiotherapy, rehabilitation, and supportive care. Particular attention was given to safety considerations, certification status, and practical experience with the device in clinical and therapeutic settings.

Participation in SEC 2026 marked an important step for SPHERE LIFE and IMMUNEXIS in expanding international collaboration and promoting innovative physiotherapeutic technologies. The companies plan to continue their scientific research efforts and further integrate their developments into practice with the goal of improving health outcomes and quality of life.